<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20191008045028N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2019-12-11</date_registration>
      <primary_sponsor>Yazd University of Medical Sciences</primary_sponsor>
      <public_title>Effect of diode laser irradiation on pro-inflammatory cytokines and mini-screw stability</public_title>
      <acronym></acronym>
      <scientific_title>Effect of 980 nm diode laser irradiation on pro-inflammatory cytokines and mini-screw stability</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2019-05-22</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>12</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/43051</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Double blinded, Placebo: Used, Assignment: Parallel, Purpose: Treatment, Randomization description: Simple randomization is done.the side of laser irradiation and the control side is determined by the coin toss of each patient, Blinding description: Banding and bonding of teeth  perform by the first examiner for all patients. Low level laser perform by the second examiner in a double-blind fashion such that the patient and the first examiner blind to the group allocation of each quadrant and the selected quadrant for laser therapy.</study_design>
      <phase>3</phase>
      <hc_freetext>patients with class II division I malocclusion or bimaxillary protrusion.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group:Mini-screws were placed between the roots of maxillary second premolar and first molar. Diode laser was irradiated with 980 nm wavelength and 100 mW output power in continuous-wave mode for 30 seconds to the occlusal and 30 seconds to the gingival part of the mini-screw at four time points: T0 (1 h after mini-screw placement), T1 (1 week later), T2 (at 1 month) and T3 (at 3 months) in one quadrant of the maxilla (laser group). Intervention 2: Control group: Simultaneously the other quadrant of the maxilla underwent pseudo-application of laser .</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
Part of the data, such as information about the main outcome, can be shared.

When:
Start of access period 6 months after printing results

To whom:
Researchers working in academic and scientific institutions

Conditions:
To promote motivation and science

Where to obtain:
s.kordi3314@yahoo.com
somaye kordi

How to obtain:
Email the responsible author

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Somaye Kordi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Department of Orthodontic, Faculty of Dentistry, Dahaye Fajr BLV, Imam Ave, Yazd, Iran</address>
        <city>Yazd</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>89195/165</zip>
        <telephone>+98 35 3621 2222</telephone>
        <email>S.kordi3314@yahoo.com</email>
        <affiliation>Yazd University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Somaye Kordi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Department of Orthodontic, Faculty of Dentistry, Dahaye Fajr BLV, Imam Ave, Yazd, Iran</address>
        <city>Yazd</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>89195/165</zip>
        <telephone>+98 35 3621 2222</telephone>
        <email>S.kordi3314@yahoo.com</email>
        <affiliation>Yazd University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Patients with bimaxillary dentoalveolar protrusion or class II division I malocclusion requiring extraction of maxillary first premolars and anterior retraction.
Good oral hygiene
Signing the informed consent forms by the patients or their parents</inclusion_criteria>
      <agemin>15 years</agemin>
      <agemax>18 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>systemic disease
history of extraction of other permanent teeth
taking medications affecting the level of pro-inflammatory cytokines such as non-steroidal anti-inflammatory drugs and corticosteroids during the study period or in the past one month prior to the onset of treatment
periodontal disease or radiographic evidence of bone loss
pregnancy during the orthodontic treatment</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code></hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword></hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Devices</i_code>
      <i_code>Placebo</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group:Mini-screws were placed between the roots of maxillary second premolar and first molar. Diode laser was irradiated with 980 nm wavelength and 100 mW output power in continuous-wave mode for 30 seconds to the occlusal and 30 seconds to the gingival part of the mini-screw at four time points: T0 (1 h after mini-screw placement), T1 (1 week later), T2 (at 1 month) and T3 (at 3 months) in one quadrant of the maxilla (laser group).</i_keyword>
      <i_keyword>Control group: Simultaneously the other quadrant of the maxilla underwent pseudo-application of laser .</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>The primary stability of mini-screws. Timepoint: at four time points: T0 (1 h after mini-screw placement), T1 (1 week later), T2 (at 1 month) and T3 (at 3 months).PTV was measured at the above mentioned four time points and one hour after laser irradiation. Method of measurement: The primary stability of mini-screws was measured by Periotest M and reported as Periotest value (PTV). At each time point, samples were collected from the PMCF to assess the concentration of IL-1B and TGF-B1.</prim_outcome>
      <prim_outcome>Inflammation around the mini-screws. Timepoint: at four time points: T0 (1 h after mini-screw placement), T1 (1 week later), T2 (at 1 month) and T3 (at 3 months).The samples were collected at the aforementioned four time points and one hour after laser irradiation and prior to the measurement of PTV. Method of measurement: PMCF samples were collected using high-purity filter papers used as paper strips to measure the concentration of IL-1β and TGF-β1.A cotton roll was used for isolation of the area and the mini-screw site was dried with air spray for 15 seconds. The paper strip was inserted into the gingival sulcus around the mini-screw and remained there for 60 s. If the Periostrip was contaminated with blood or saliva, sampling was repeated. Immediately after PMCF collection, the paper strips were transferred into sterile 1.5 mL microtubes containing 250 µL of phosphate buffered saline. Parafilm (Bemis; Neenah, Wisconsin, USA) was used to seal the tubes. The vials were stored at -20°C until collection of all samples and onset of experiment. The PMCF samples were used to measure the concentration of IL-1β using a kit designed for this purpose (Diaclone SAS, Besancon, France) and TGF-β1 using the respective kit (IBL International GMBH, Germany) by enzyme-linked immunosorbent assay according to the manufacturers’ instructions.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>At each time point, samples were collected from the PMCF to assess the concentration of IL-1B and TGF-B1. Timepoint: at four time points: T0 (1 h after mini-screw placement), T1 (1 week later), T2 (at 1 month) and T3 (at 3 months). Method of measurement: The PMCF samples were used to measure the concentration of IL-1B using a kit designed for this purpose (Diaclone SAS, Besancon, France) and TGF-B1 using the respective kit (IBL International GMBH, Germany) by enzyme-linked immunosorbent assay according to the manufacturers’ instructions.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Yazd University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2018-05-30</approval_date>
        <contact_name>Ethics committee of  shahid sadoughi University of Medical Sciences</contact_name>
        <contact_address>Faculty of Dentistry, Dahaye Fajr BLV, Imam Ave, Yazd, Iran Yazd Yazd Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
